Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
Aneesh Dhorepatil, Tariq Thannoun, Rohan Samson, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 10

Showing 10 citing articles:

New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review
Jorge Jalil, Luigi Gabrielli, María Paz Ocaranza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 8
Obesity, heart failure with preserved ejection fraction, and the role of glucagon‐like peptide‐1 receptor agonists
Giuliana Cimino, Muthiah Vaduganathan, Carlo Lombardi, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 2, pp. 649-661
Open Access | Times Cited: 21
Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications
Mariana M. Rodrigues, Luiz Menezes Falcão
International Journal of Cardiology (2025), pp. 133182-133182
Closed Access
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Alana Aragón‐Herrera, Sandra Moraña‐Fernández, Manuel Otero-Santiago, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114535-114535
Open Access | Times Cited: 10
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
Tianyu Wang, Qiang Yang, Xinyi Cheng, et al.
Heart Failure Reviews (2024)
Closed Access | Times Cited: 1
Серцева недостатність зі збереженою фракцією викиду та метаболічний синдром. Основні фактори розвитку, роль епікардіального жиру
A.M. Sokolova, V.V. Pushkarev, Л.К. Соколова, et al.
Endokrynologia (2024) Vol. 29, Iss. 1, pp. 42-57
Open Access | Times Cited: 1
Серцева недостатність зі збереженою фракцією викиду: основні молекулярні і клітинні механізми розвитку
A.M. Sokolova, V.V. Pushkarev, Л.К. Соколова, et al.
Ukrainian Journal of Cardiology (2024) Vol. 31, Iss. 1, pp. 90-102
Open Access
Mediating Effect of the NLR on the Relationship Between HbA1c and Left Atrial Stiffness in Overweight Patients With Hypertension
Ri Zhang, Yu Pan, Yong K Ren, et al.
American Journal of Hypertension (2024) Vol. 37, Iss. 8, pp. 597-603
Open Access
Retrospective Study on Short-Term Reverse Cardiac Remodeling in Obese Patients Undergoing Sleeve Gastrectomy
Carmine Izzo, Valeria Visco, Alessandra Cirillo, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 12, pp. 389-389
Open Access
Sodium–Glucose Cotransporter-2 Inhibitors: An Old Medication With New Indication in Heart Failure With Preserved Ejection Fraction
Mohamed Toufic El Hussein, Cassandra Reeves
The Journal for Nurse Practitioners (2023) Vol. 19, Iss. 8, pp. 104716-104716
Closed Access
Page 1

Scroll to top